Atherosclerotic Cardiovascular Diseases Recruiting Phase 2 / 3 Trials for Clazakizumab (DB12849)

Back to Atherosclerotic Cardiovascular Diseases

Also known as: Atherosclerotic Cardiovascular Disease / Atheromatosis / Atherosclerotic heart disease of native coronary artery / Atherosclerosis / Atherosclerosis (morphologic abnormality) / Arteriosclerotic vascular disease (disorder) / Arteriosclerosis / Arteriosclerosis (morphologic abnormality) / Vascular sclerosis (morphologic abnormality)

IndicationStatusPhase
DBCOND0078488 (Atherosclerotic Cardiovascular Diseases)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05485961
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing DialysisSupportive Care